HER2-positive breast cancer is defined by circumferential membrane staining that is complete, intense, and in >10% of tumor cells in immunohistochemistry (IHC 3+) and/or in situ hybridization (ISH)-positive [6]. The gene discussed is ERBB2; the disease is neoplasm.